The International Session
In the International Sessions, General Platform and Poster Presentations are available and English is the official language. If you are the first speaker and 40 years old or younger as of May 25, 2023, you can apply for Young Investigator Award (see the Abstract Submission Form）
September 27 to
October 28, 2022 (JST）
noon November 7, 2022(JST)
※Abstract Submission has been closed.
Invited speakers shall be individually requested to submit the abstract and CV.
General Instruction for Submission to the International Session
- Affiliation is addressed as follows: Institution, city/state/province & country name (ex.) Department of Pediatrics, University of Toronto, Toronto, ON, Canada
- Submitted abstracts will be reviewed by the Program Committee and the Executive Committee of the Congress to determine acceptance. Acceptance or rejection will be announced to the applicants via e-mail by mid-January, 2023.
- All abstracts must not conflict with the Ethical Codes of the Japanese Society of Child Neurology to protect privacy of patients. For all studies dealing with experimental work involving human subjects, specify that informed consent was obtained following a full explanation of the procedure(s) undertaken. Patients should be referred to by number; do not use real names, initials or hospital numbers. Also, the design of special scientific research (e.g. genetic research and regenerative medicine) should be approved by the ethical committee of the institution, and the approval status should be clearly stated in the abstract. The institutional approval may not be required for genetic testing primarily for a diagnostic purpose. When submitting abstracts, please be along with the ethical rules regarding personal information related to patients. If you use videos or photo images of patients, please be sure to pay careful attention to ethical codes and to obtain permission from the patient(s) (or, when applicable, the next of kin).
- Duplicate reports are not accepted in the 65th Annual Meeting of JSCN. All abstracts strictly adhere to this policy. The contents of the abstract must not have been presented at any previous conference or event. However, it does not apply to 1) the presentations by a special request in the meeting (e.g. special lectures, symposia, workshops, seminars), 2) reports in different languages, 3) reports of already published contents, or 4) reports presented at research group meetings.
When your abstract may have a possibility of duplicate presentation, you should inform the Secretariat of the 65th Annual Meeting of JSCN regarding the possibility of duplicate presentation with clear indication of the name and date of the corresponding meeting, the title of the previous presentation, and reasons of the second report.
- Any corrections to be made to your abstract will be your own responsibility.
- In all presentations, you should make and upload a brief video presentation that succinctly highlights the essential point of your presentation in about 90 sec (range 60 – 120 sec) (“Highlight Video Clip”) . Registration is scheduled to begin in mid-April 2023. This video clip is reviewed online by the congress attendants in addition to the General Platform or Poster Presentation.
Conflicts of Interest of the author
Conflicts of interest (COI) of the speaker(s) must be clearly indicated and the necessary information must be disclosed as specified. The first speaker and co-speakers are required to disclose COI, if any, for the entire research period, which refers to salaries through such as dual employment, lecture fees, manuscript fees, research expenses, scholarship donations, provision of personnel, affiliation with endowed courses, and others from commercial companies or organizations. In the JSCN the first speaker and co-speakers who have COI status to be disclosed and are not living in Japan should fill out a self-report form (Form 1E) and email a password‐protected signed self‐declaration form with the abstract to jscn65‐email@example.com. Also, please email the password for the self‐reported file separately to jscn65‐firstname.lastname@example.org. Japanese speakers are requested to refer to the corresponding instruction in Japanese.Please note that the disclosure of the conflict of interest of co-speakers is also required.
Please submit the abstract by clicking the button below.
The online Abstract Submission System does not allow abstract submission using browsers other than Firefox, Google Chrome, Microsoft Edge, and Safari. Please do not use any other browsers. The latest version of each browser is assumed to be used.
- The title of the abstract should be less than 120 characters in single-byte, including spaces.
- The text of the abstract should be less than 1,500 characters in single-byte.
- The maximum number of co-speakers is 14, and the maximum number of institutional affiliations is 10.
- The abstract should clearly and specifically describe the intent of the presentation in the order of purpose, methods, results, and conclusions.
- Be sure to list the full name of the institutional affiliation, your specialty, and your department.
- All similar departments should be listed using the same name; for example, "Department of Pediatric Science" and "Pediatric Course" should be listed as "Department of Pediatrics."
- For numbers, Arabic numbers (1, 2, 3) should be used. For years, the western calendar year should be used.
- The entire text in the English language should be in lower-case letters except for proper nouns and the first letter of the first word in a sentence. Names of persons, pharmaceuticals, and places should be in their original language.
- Confirmation of submission will be sent via e-mail to your address. If you do not receive a confirmation e-mail within 30 min of submitting the abstract, please contact us at email@example.com